Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

NCT00413335 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Impaired Glucose Tolerance
Type 2 Diabetes Mellitus

Interventions

DRUG: Rosiglitazone
DRUG: Placebo

Sponsor

Yale University